Applied Molecular Transport Competitors and Similar CompaniesClear all

Polyplus-transfection's competitors and similar companies include Corvidia Therapeutics, Orum Therapeutics and Ermium Therapeutics.
Polyplus-transfection
Polyplus-transfection
Polyplus-transfection is a biotechnology company that develops and sells innovative solutions for the delivery of nucleic acids in research, bioproduction, and therapeutics.
Corvidia Therapeutics
Corvidia Therapeutics
Corvidia Therapeutics is a biotechnology company. It develops next-generation precision cardiovascular therapies.
Orum Therapeutics
Orum Therapeutics
Orum Therapeutics is a biotech company creating cell-penetrating therapeutic antibodies.
Ermium Therapeutics
Ermium Therapeutics
Ermium Therapeutics is a biotech company providing therapies for auto-immune diseases.
Founding Date
Founding Date
2002
Founding Date
2015
Founding Date
2016
Founding Date
2019
Type
Type
Private
Type
Subsidiary
Type
Private
Type
Private
Tags
Locations
Locations
Illkirch-Graffenstaden, FR HQ
New York, US
Locations
Waltham, US HQ
Locations
KR HQ
Cambridge, US
Locations
Roubaix, FR HQ
Paris, FR
Employees
Employees
1133% increase
Employees
5
Employees
512% increase
Employees
233% decrease

Funding

Latest funding round
Latest funding round
$ 3.2m (over 15 years ago)
Latest funding round
N/A
Latest funding round
$ 30m (almost 7 years ago)
Latest funding round
N/A
Total funding raised
Total funding raised
$ 3.2m
Total funding raised
$ 86m
Total funding raised
$ 38m
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Corvidia Therapeutics
HQ
Waltham, US

Corvidia Therapeutics is a biotechnology company. It develops next-generation precision cardiovascular therapies.

View company
Orum Therapeutics
HQ
KR
Employees
51↑ 2% increase

Orum Therapeutics is a biotech company creating cell-penetrating therapeutic antibodies.

View company
Ermium Therapeutics
HQ
Roubaix, FR
Employees
2↓ 33% decrease

Ermium Therapeutics is a biotech company providing therapies for auto-immune diseases.

View company